logo
Select company
Select metric
8%Return on Assets
VS
Market
86
Sector
92
Industry
94
History
83
$ 2.14Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 78.49M$ 6.28M8%
3/31/2025$ 73.89M$ 3.91M5.29%
12/31/2024$ 73.42M$ 2.93M3.99%
9/30/2024$ 61.56M$ -9.61M-15.6%
6/30/2024$ 91.54M$ -14.69M-16.05%
3/31/2024$ 89.83M$ 6.85M7.62%
12/31/2023$ 84.43M$ 8.31M9.84%
9/30/2023$ 87.57M$ 10.62M12.12%
6/30/2023$ 88.42M$ 8.9M10.07%
3/31/2023$ 66.56M$ -15.77M-23.7%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -9.17%.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average ROA has been -11.8%.
  • The median ROA for PROTALIX BIOTHERAPEUTICS INC during this period was -14.45%
  • PROTALIX BIOTHERAPEUTICS INC reached its highest ROA over the past 5 years at 12.12%.
  • The lowest ROA recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe -37.44%

PROTALIX BIOTHERAPEUTICS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
CSBR : CHAMPIONS ONCOLOGY INC 9.66%THTX : THERATECHNOLOGIES INC -17.86%BDTX : BLACK DIAMOND THERAPEUTICS INC 8.68%SPRO : SPERO THERAPEUTICS INC -86.29%ENTA : ENANTA PHARMACEUTICALS INC -30.57%CELU : CELULARITY INC -61.3%IVVD : INVIVYD INC -123.55%DOMH : DOMINARI HOLDINGS INC -17.4%SGMO : SANGAMO THERAPEUTICS INC -66.21%ALEC : ALECTOR INC -32.35%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -6.63M ] / Assets [ $ 72.31M ]
(=) ROA [ -9.17% ]

PLX - Return on Assets, Last 5 years

-37.44%

Minimum

Dec 31, 2021

12.12%

Maximum

Sep 30, 2023

-11.8%

Average

-14.45%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.09% with a standard deviation of 10.64%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.45K
min-33.42%
max33.98%
average0.09%
median1.53%
std10.64%